Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Cavernous Angiomas With Symptomatic Hemorrhage
NCT02603328Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jul 2018
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in cerebral cavernous malformation (CCM), sponsored by University of Chicago. Started Jul 2018; status: completed.
02
Drugs
atorvastatin
03
Conditions
cerebral cavernous malformation (CCM)
Beyond the preview
Go deeper on NCT02603328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603328.